|
CCDC12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.740400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.525200E-01 |
| Normal-vs-Stage2 |
9.793200E-01 |
| Normal-vs-Stage3 |
8.287200E-01 |
| Normal-vs-Stage4 |
3.272600E-01 |
| Stage1-vs-Stage2 |
8.723000E-01 |
| Stage1-vs-Stage3 |
9.363200E-01 |
| Stage1-vs-Stage4 |
3.131400E-01 |
| Stage2-vs-Stage3 |
8.484000E-01 |
| Stage2-vs-Stage4 |
4.378200E-01 |
| Stage3-vs-Stage4 |
4.133000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.622800E-01 |
| Normal-vs-AfricanAmerican |
4.930400E-01 |
| Normal-vs-Asian |
8.032800E-01 |
| Caucasian-vs-AfricanAmerican |
6.375800E-01 |
| Caucasian-vs-Asian |
5.607000E-01 |
| AfricanAmerican-vs-Asian |
4.149600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.121600E-01 |
| Normal-vs-Female |
6.393600E-01 |
| Male-vs-Female |
3.154600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.622800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.166600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.466800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.969200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.324400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.360600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.166200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.900600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.383400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.190400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.045600E-02 |
| Classical-VS-Follicular |
9.164400E-01 |
| Classical-VS-Other |
4.843000E-01 |
| Classical-VS-Normal |
8.367600E-01 |
| Tall-VS-Follicular |
7.105800E-02 |
| Tall-VS-Other |
4.506100E-02 |
| Tall-VS-Normal |
5.063900E-02 |
| Follicular-VS-Other |
6.092400E-01 |
| Follicular-VS-Normal |
9.339600E-01 |
| Other-VS-Normal |
5.184400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.912800E-01 |
| Normal-vs-N1 |
6.598200E-01 |
| N0-vs-N1 |
5.963600E-01 |
|
|
